QUINAPRIL HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Quinapril Hydrochloride, and what generic alternatives are available?
Quinapril Hydrochloride is a drug marketed by Actavis Elizabeth, Actavis Labs Fl Inc, Ani Pharms, Apotex Inc, Aurobindo Pharma Ltd, Chartwell Rx, Invagen Pharms, Lupin, Mylan, Norvium Bioscience, Prinston Inc, Sun Pharm Inds Ltd, Apotex, and Aurobindo Pharma. and is included in nineteen NDAs.
The generic ingredient in QUINAPRIL HYDROCHLORIDE is hydrochlorothiazide; quinapril hydrochloride. There are thirty-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; quinapril hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for QUINAPRIL HYDROCHLORIDE?
- What are the global sales for QUINAPRIL HYDROCHLORIDE?
- What is Average Wholesale Price for QUINAPRIL HYDROCHLORIDE?
Summary for QUINAPRIL HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 14 |
NDAs: | 19 |
Finished Product Suppliers / Packagers: | 9 |
Raw Ingredient (Bulk) Api Vendors: | 85 |
Clinical Trials: | 27 |
Patent Applications: | 3,067 |
What excipients (inactive ingredients) are in QUINAPRIL HYDROCHLORIDE? | QUINAPRIL HYDROCHLORIDE excipients list |
DailyMed Link: | QUINAPRIL HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for QUINAPRIL HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
AHEPA University Hospital | Phase 4 |
University of Nebraska | Phase 4 |
Pfizer |
Pharmacology for QUINAPRIL HYDROCHLORIDE
Drug Class | Angiotensin Converting Enzyme Inhibitor |
Mechanism of Action | Angiotensin-converting Enzyme Inhibitors |